Publication:
Rationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: the AGTP II trial

dc.contributor.authorGastelurrutia, Paloma
dc.contributor.authorGálvez Montón, Carolina
dc.contributor.authorCámara, María Luisa
dc.contributor.authorBustamante Munguira, Juan
dc.contributor.authorGarcía Pavia, Pablo
dc.contributor.authorAvanzas, Pablo
dc.contributor.authorSan Román, J Alberto
dc.contributor.authorPascual Figal, Domingo
dc.contributor.authorTeresa, Eduardo de
dc.contributor.authorCrespo Leiro, María G.
dc.contributor.authorManito, Nicolás
dc.contributor.authorNúñez, Julio
dc.contributor.authorFernández Avilés, Francisco
dc.contributor.authorCaballero, Angel
dc.contributor.authorTeis, Albert
dc.contributor.authorLupón, Josep
dc.contributor.authorBrugada, Ramón
dc.contributor.authorMartín, Carlos
dc.contributor.authorSilva, Jacobo
dc.contributor.authorRevilla Orodea, Ana
dc.contributor.authorCánovas López, Sergio
dc.contributor.authorMelero, Jose M
dc.contributor.authorCuenca Castillo, Jose J
dc.contributor.authorGonzález Pinto, Angel
dc.contributor.authorBayes Genis, Antoni
dc.contributor.departmentCirugía, Pediatría y Obstetricia y Ginecología
dc.date.accessioned2024-07-19T10:00:48Z
dc.date.available2024-07-19T10:00:48Z
dc.date.issued2017-08-04
dc.description© The authors 2017. This manuscript version is made available under the CC-BY-NC 4.0 license http://creativecommons.org/licenses/by-nc/4.0/ This document is the Published version of a Published Work that appeared in final form in BMJ Open. To access the final edited and published work see https://doi.org/10.1136/bmjopen-2017-017187
dc.description.abstractIntroduction Cardiac adipose tissue is a source of progenitor cells with regenerative capacity. Studies in rodents demonstrated that the intramyocardial delivery of cells derived from this tissue improves cardiac function after myocardial infarction (MI). We developed a new reparative approach for damaged myocardium that integrates the regenerative properties of cardiac adipose tissue with tissue engineering. In the adipose graft transposition procedure (AGTP), we dissect a vascularised flap of autologous pericardial adipose tissue and position it over the myocardial scarred area. Following encouraging results in acute and chronic MI porcine models, we performed the clinical trial (NCT01473433, AdiFLAP trial) to evaluate safety in patients with chronic MI undergoing coronary artery bypass graft. The good safety profile and trends in efficacy warranted a larger trial. Study design The AGTP II trial (NCT02798276) is an investigator initiated, prospective, randomised, controlled, multicentre study to assess the efficacy of the AGTP in 108 patients with non-revascularisable MI. Patients will be assigned to standard clinical practice or the AGTP. The primary endpoint is change in necrotic mass ratio by gadolinium enhancement at 91 and 365 days. Secondary endpoints include improvement in regional contractibility by MRI at 91 and 365 days; changes in functional MRI parameters (left ventricular ejection fraction, left and right ventricular geometric remodelling) at 91 and 365 days; levels of N-terminal prohormone of brain natriuretic peptide (NT-proBNP) at 7, 91 and 365 days; appearance of arrhythmias from 24 hour Holter monitoring at 24 hours, and at 91 and 365 days; all cause death or re-hospitalisation at 365 days; and cardiovascular death or re-hospitalisation at 365 days. Ethics and dissemination The institutional review board approved the trial which will comply with the Declaration of Helsinki. All patients will provide informed consent. It may offer a novel, effective and technically simple technique for patients with no other therapeutic options. The results will be submitted to indexed medical journals and national and international meetings.es
dc.formatapplication/pdfes
dc.format.extent7es
dc.identifier.citationBMJ Open, 2017, Vol. 7, Issue 8: e017187
dc.identifier.doihttps://doi.org/10.1136/bmjopen-2017-017187
dc.identifier.issnElectronic: 2044-6055
dc.identifier.urihttp://hdl.handle.net/10201/143244
dc.languageenges
dc.publisherBMJ Publishing Group
dc.relationThe AGTP II trial is an investigator initiated study, sponsored by the Germans Trias i Pujol Research Institute. It is supported by grants from Ministerio de Educación y Ciencia (SAF2014-59892-R), Ministerio de Economía y Competitividad (Juan de la Cierva, JCI-2012-14025), Fundació La MARATÓ de TV3 (201502, 201516) and Generalitat de Catalunya (SGR 2014 , CERCA Programme and PERIS Programme, Departament de Salut SLT002/16/00234, SLT002_16_00209). Additional funds will be provided by Red de Terapia Celular-TerCel (RD16/0011/0006) and CIBER Cardiovascular (CB16/11/00403), as part of the Plan Nacional de I+D+I, and cofunded by ISCIII-Sudirección General de Evaluación and Fondo Europeo de Desarrollo Regional (FEDER), and “La Caixa” Banking Foundation. This work is developed within the AdvanceCat project with the support of ACCIÓ (Catalonia Trade & Investment; Generalitat de Catalunya) under the Catalonian European Regional Development Fund (ERDF) operational programme 2014-2020.es
dc.relation.publisherversionhttps://bmjopen.bmj.com/content/7/8/e017187
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.rightsAtribución-NoComercial 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.titleRationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: the AGTP II triales
dc.typeinfo:eu-repo/semantics/articlees
dspace.entity.typePublicationes
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
e017187.full.pdf
Size:
1.59 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.26 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections